Boisbriand, Canada Clinical Trials

A listing of Boisbriand, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 107 clinical trials
GPS Project Evaluation of the Impact of the Reorganization of Work Into a Family Medicine Group on Pharmacotherapy and Support for the Autonomy of Seniors With Major Neurocognitive Disorders

The model of care tested in the GPS project aims to optimize pharmacotherapy for seniors undergoing cognitive assessment or suffering from major neurocognitive disorder (MCND) at home. The goal is to reduce polymedication, inappropriate medications and the treatment burden of seniors and to maintain their cognitive health, quality of life …

GMF Bordeaux-Cartierville
 (8.6 away) Contact site
  • 0 views
  • 22 Mar, 2022
  • +1 other locations
A Phase 3 Multicenter Study to Evaluate the Safety and Efficacy of AGN-151586 for the Treatment of Glabellar Lines in Toxin-Naïve Subjects

Facial lines that develop from repeated facial expression, such as glabellar lines (GL), are typically treated by selectively weakening specific muscles with small quantities of botulinum toxin. AGN-151586 is an investigational product being developed for the treatment of GL. The purpose of this study is to evaluate the safety and …

Clinique D /ID# 239653
 (6.5 away) Contact site
  • 3 views
  • 16 Sep, 2022
  • +15 other locations
Characterization of Arrhythmia Substrate to Ablate Persistent Atrial Fibrillation (COAST-AF RCT)

A multicentre, parallel group, two arm, single-blinded randomized clinical trial, assessing the efficacy of a patient-tailored catheter ablation (CA) strategy guided by atrial scar mapping in addition to pulmonary vein isolation (PVI) when compared to PVI alone in patients with persistent atrial fibrillation (AF).

holter monitor
fibrillation
arrhythmia
pulmonary vein isolation
persistent atrial fibrillation
Sacre-Coeur Hospital
 (8.1 away) Contact site
  • 28 views
  • 14 Feb, 2022
  • +12 other locations
Intra-articular Vancomycin Powder in Knee and Hip Arthroplasty

The purpose of this study is to compare infection rates when patients, elected for primary or aseptic revision THA / TKA, have a single intravenous antibiotic dose versus one single intravenous antibiotic dose in combination with intra-articular antibiotics. This is a prospective, randomized clinical survey on selected outcome measurements on …

Hopital Sacr -Coeur de Montreal
 (8.1 away) Contact site
  • 0 views
  • 21 Jul, 2021
  • 1 location
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer (TAILOR RT)

The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming …

breast-conserving surgery
invasive carcinoma
hormone therapy
mastectomy
immunostimulant
Hopital de la Cite-de-la-Sante
 (6.2 away) Contact site
  • 760 views
  • 27 Jul, 2022
  • +325 other locations
Safety And Efficacy Study Of Intravenous (IV) Administration Of Elezanumab To Assess Change In Upper Extremity Motor Score (UEMS) In Adult Participants With Acute Traumatic Cervical Spinal Cord Injury (SCI) (ELASCI)

Acute Spinal Cord Injury (SCI) is a rare injury that leads to permanent neuromotor impairment and sudden disability. Approximately 25,000 people experience cervical SCI in the United States, Europe, and Japan every year. The purpose of this study is to see if elezanumab is safe and assess change in Upper …

acute spinal cord injury
spinal injury
spinal cord disorder
spinal cord
cervical spinal cord injury
CIUSSS du Nord-de-l'ile-de-Montréal_Hopital du Sacré-Coeur de Montréal /ID# 215210
 (8.1 away) Contact site
  • 626 views
  • 11 Aug, 2022
  • +37 other locations
Brain Oxygen Optimization in Severe TBI, Phase 3 (BOOST3)

BOOST3 is a randomized clinical trial to determine the comparative effectiveness of two strategies for monitoring and treating patients with traumatic brain injury (TBI) in the intensive care unit (ICU). The study will determine the safety and efficacy of a strategy guided by treatment goals based on both intracranial pressure …

coma
ct scan
traumatic brain injury
CIUSSS-NIM Hopital du Sacre - Coeur de Montreal
 (8.1 away) Contact site
  • 258 views
  • 22 Mar, 2022
  • +34 other locations
Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates (CARSK)

The Canadian Australasian Randomized Trial of Screening Kidney Transplant Candidates for Coronary Artery Disease (CARSK) will test the hypothesis that eliminating the regular use of non-invasive screening tests for CAD AFTER waitlist activation is not inferior to regular (i.e., annual) screening for CAD during wait-listing for the prevention of Major …

renal failure
kidney failure
kidney transplant
arteriopathy
coronary disease
CHU de Quebec-Universite Laval's L'Hotel-Dieu de Quebec
 (6.1 away) Contact site
  • 1 views
  • 02 Mar, 2022
  • +14 other locations
Efficacy Comparison of Cobolimab + Dostarlimab + Docetaxel to Dostarlimab + Docetaxel to Docetaxel Alone in Participants With Advanced Non-Small Cell Lung Cancer Who Have Progressed on Prior Anti- Programmed Death-ligand 1 (PD-[L]1) Therapy and Chemotherapy (COSTAR Lung)

This is a multi-center, parallel group treatment, Phase 2 open label study evaluating cobolimab in combination with dostarlimab and docetaxel in participants with advanced Non-small cell Lung Cancer (NSCLC) who have progressed on prior anti-PD-(L)1 therapy and chemotherapy.

carcinoma
measurable disease
cancer chemotherapy
lung carcinoma
docetaxel
GSK Investigational Site
 (8.1 away) Contact site
  • 14 views
  • 04 May, 2022
  • +97 other locations
Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple Myeloma (DREAMM 8)

This study will evaluate the efficacy and safety of belantamab mafodotin in combination with pomalidomide and dexamethasone (Arm A) compared with that of combination of pomalidomide, bortezomib and dexamethasone (Arm B) in participants with relapsed/refractory multiple myeloma (RRMM).

measurable disease
dexamethasone
lenalidomide
bortezomib
cancer
GSK Investigational Site
 (8.1 away) Contact site
  • 19 views
  • 21 Jul, 2022
  • +117 other locations